Comparing 2 hypotheses side-by-side
TDP-43 loss-of-function causes inclusion of a poison exon in STMN2 mRNA, leading to motor neuropathy and contributing to hippocampal axonal dysfunction. Splice-switching oligonucleotides or small molecules that sterically block the poison exon splice site restore STMN2 expression, prevent axonal degeneration, and preserve synaptic connectivity. --- ### Mechanistic Pathway Diagram ```mermaid graph TD A["PTBP1<br/>Downregulation"] --> B["PTBP2<br/>Expression Restoration"] B --> C["STMN2<
**SASP-Mediated Complement Cascade Amplification in Alzheimer's Disease** **Overview: Senescence, Inflammation, and Synaptic Loss** Cellular senescence—a state of irreversible growth arrest accompanied by a pro-inflammatory secretome—accumulates dramatically with age and in Alzheimer's disease. Senescent astrocytes and microglia secrete the senescence-associated secretory phenotype (SASP), a cocktail of cytokines, chemokines, proteases, and critically, complement cascade initiators including C
| Dimension | Stathmin-2 Splice Switching to | SASP-Mediated Complement Casca |
|---|---|---|
| Mechanistic | 0.850 | 0.750 |
| Evidence | 0.900 | 0.700 |
| Novelty | 0.700 | 0.850 |
| Feasibility | 0.800 | 0.750 |
| Impact | 0.880 | 0.800 |
| Druggability | 0.850 | 0.850 |
| Safety | 0.650 | 0.600 |
| Competition | 0.750 | 0.800 |
| Data | 0.900 | 0.750 |
| Reproducible | 0.850 | 0.700 |
4 rounds · quality: 0.50
# Novel Therapeutic Hypotheses: RNA Binding Protein Dysregulation Across ALS-FTD-AD ## Hypothesis 1: RBFOX1 Splicing Restoration to Correct Circuit Hyperexcitability Across the Neurodegeneration Sp...
# Critical Evaluation of RNA Binding Protein Therapeutic Hypotheses in Neurodegeneration ## Hypothesis 1: RBFOX1 Splicing Restoration ### Specific Weaknesses in Evidence **1. Limited human tissue...
# Practical Drug Development Assessment: RNA Binding Protein Hypotheses in Neurodegeneration ## Executive Summary These hypotheses cluster around an emerging but challenging therapeutic space: RNA...
```json { "ranked_hypotheses": [ { "rank": 1, "hypothesis_id": "H5", "hypothesis_name": "PTBP1-Mediated Glial Reprogramming to Replace Lost Neurons", "target": "PTBP1",...
4 rounds · quality: 0.60
# Novel Therapeutic Hypotheses for Age-Related Neurodegeneration ## 1. Senescence-Activated NAD+ Depletion Rescue **Description:** Senescent glial cells upregulate CD38 NADase, creating local NAD+ de...
# Novel Therapeutic Hypotheses for Age-Related Neurodegeneration ## 1. Senescence-Activated NAD+ Depletion Rescue **Description:** Senescent glial cells upregulate CD38 NADase, creating local NAD+ de...
# Critical Evaluation of Age-Related Neurodegeneration Hypotheses ## 1. Senescence-Activated NAD+ Depletion Rescue ### Specific Weaknesses: - **Spatial specificity unclear**: No evidence that CD38 u...
# Critical Evaluation of Age-Related Neurodegeneration Hypotheses ## 1. Senescence-Activated NAD+ Depletion Rescue ### Specific Weaknesses: - **Spatial specificity unclear**: No evidence that CD38 u...
No shared papers found across 28 total unique citations. These hypotheses draw from independent evidence bases.